Cargando…
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines
In early 2020, adult volunteers were invited to participate in a first-in-human trial of the COVID-19 vaccine, ChAdOx1 nCoV-19, in the United Kingdom (UK) at the height of the global pandemic when there was uncertainty regarding vaccine efficacy and side-effects. We conducted a retrospective survey...
Autores principales: | Thomas, Tonia M., Hodgson, Susanne H., Emary, Katherine, Patrick-Smith, Maia, te Water Naude, Rebecca, Stuart, Arabella S. V., Henry, John, English, Marcus, Moore, Maria, Douglas, Naomi, Pollard, Andrew J., Vanderslott, Samantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161940/ https://www.ncbi.nlm.nih.gov/pubmed/37138460 http://dx.doi.org/10.1080/21645515.2023.2203023 |
Ejemplares similares
-
Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
por: Vanderslott, Samantha, et al.
Publicado: (2021) -
Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing
por: Vanderslott, Samantha, et al.
Publicado: (2021) -
Foundations for improved vaccine correlate of risk analysis using positive-unlabeled learning
por: Kelkar, Natasha S., et al.
Publicado: (2023) -
Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010) -
Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)